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ABSTRACT 
Background: Myeloma-related disorders are characterized by proliferation of neoplastic plasma cell or immature immuno-
globulin secreting B-lymphocytes, and include multiple myeloma, M-macroglobulinemia and extra-medullary plasmacytoma 
(cutaneous or extra-cutaneous). Solitary osseous plasmacytoma (SOP) is considered an unique entity among extra-medullary 
extra-cutaneous plasmacytoma. It is an unusual neoplasia in dogs, predominantly found in middle-aged to older animals, 
with a higher incidence in bones of axial skeleton. Dogs with vertebral SOP present neurological signs related to spinal 
cord compression, but progression to multiple myeloma is related to a poor outcome. As in humans, progression to mul-
tiple myeloma occurs in most cases, although it may take months or years from its initial presentation. SOP’s biological 
behaviour, incidence and prognostic are rarely documented. Chemotherapy with melphalan and prednisolone represent 
the most used protocol for multiple myeloma. However, in SOP, the combination of chemotherapy with local approaches 
is controversial before the evidence of systemic disease. This paper aims at reporting a case of SOP in a lumbar vertebrae 
of a dog, with systemic involvement. 
Case: A 11-year old male mixed breed dog was attended presenting muscle weakness, lethargy, anorexia, adipsia and in-
tense pain manifestation. The dog also presented multiple skin nodules, previously diagnosed as a plasmacytoma, through 
cytology. The dog’s poor clinical condition and aggressive temper, associated with suspicious of an advanced myeloma-
related disorder, resulted in the decision for humanized euthanasia. At necropsy, a pale, friable and hemorrhagic mass 
was identified on the L3 lumbar vertebrae, associated with an osteolytic bone lesion and spinal cord compression. Histo-
pathological analyses revealed proliferation of plasma cells, with pale perinuclear halo, moderate cellular pleomorphism, 
10 binucleated cells and 10 mitotic figures per 10 high power fields, compatible with extramedullary plasmacytoma of 
the mature type, in the lumbar vertebrae (SOP). It was also seen myeloma-related lesions in the skin and subcutaneous, 
prostate, heart, superficial mandibular and axillary lymph nodes
Discussion: Solitary osseous plasmacytoma is a myeloma-related disorder rarely reported in dogs. Its biological behav-
iour is poorly characterized, however progression for multiple myeloma is common in humans and dogs, and it is related 
to a poor outcome. As the present report, systemic progression of SOP has been previously described and although an 
overt bone marrow infiltration was not detected, such possibility can not be excluded, once multiple myeloma distribu-
tion in the bone marrow is often multifocal. Although chemotherapy is the treatment of choice for multiple myeloma, its 
indication for SOP is conditioned to the evidence of systemic disease. It might delay tumour progression, but its early 
implementation may favor the selection of resistant neoplastic clones, making it ineffective when progression to multiple 
myeloma occurs. In humans radiotherapy is the treatment of choice for SOP, however it may be indicated in association 
to surgery. A retrospective study showed a higher survival rate in patients with SOP in the axial skeleton, which received 
surgical treatment combined with radiotherapy, if compared to those treated with surgery or radiotherapy alone. Decision 
for euthanasia was made based on the suspicious of advanced myeloma-related disorder, patient’s medical condition and 
aggressive temper, which limited diagnostic investigation and treatment.
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INTRODUCTION
Myeloma-related disorders are characterized 
by proliferation of neoplastic plasma cell or immature 
immunoglobulin secreting B-lymphocytes, and include 
multiple myeloma, M-macroglobulinemia and extra-me-
dullary plasmacytoma (cutaneous or extra-cutaneous). 
Nevertheless, the solitary osseous plasmacytoma (SOP) 
is described, by some authors, as a specific pathology 
among the extra-cutaneous / extra-medullary plasmacyto-
ma [5,18]. In humans, SOP represent 3% of all cases of 
myeloma-related disorders [9], and have been described 
infrequently in dogs, affecting mostly middle-aged to 
older animals [17], with a higher incidence in the axial 
skeleton [14,15,17]. As in humans, progression to multi-
ple myeloma occurs in most cases, although it may take 
months or years from its initial presentation [17]. 
Treatment decision is based on affected site, 
extension and systemic involvement [18]. Surgery may 
be indicated prior to radiotherapy for spinal cord decom-
pression and stabilization [17]. This association is also 
recommended in cases whose injury resulted in unstable 
long-bones fractures [21]. Nevertheless, radiotherapy 
may be used as a single treatment, in dogs with stable 
long-bones fractures or vertebral involvement, without 
spinal cord compression [17]. Even when local control is 
successful, most of these patients will progress to multi-
ple myeloma [12,17]. Chemotherapy with melphalan and 
prednisolone represent the most used protocol for mul-
tiple myeloma [18]. However, in SOP, the combination 
of chemotherapy with local approaches is controversial 
before the evidence of systemic disease [17,22]. In hu-
mans, chemotherapy doesn’t prevent the progression of 
SOP to multiple myeloma, but can delay it [4].
This paper aims at reporting a case of a SOP 
in a lumbar vertebrae of a dog, with systemic involve-
ment, including skin, prostate, hearth and lymph nodes, 
in order to increase information about occurrence and 
biological behaviour of this neoplasm. 
CASE 
A 11-year-old male mixed breed dog was atten-
ded at the Veterinary Hospital Prof. Ricardo Alexandre 
Hippler, at University of Vila Velha- ES, Brazil, with 
a history of muscle weakness, at approximately one 
month ago, lethargy, anorexia, adipsia and intense pain 
manifestation. The dog also presented multiple skin 
nodules, first identified one month ago and  diagnosed 
as a plasmacytoma, through cytology.
At physical examination, patient showed mild 
dehydration, and multiple nodular lesions measuring 
1 to 2 cm (Figure 1), in the neck, pre-scapular and 
perianal regions, besides allodynia and reluctance to 
move. Patient’s aggressive temper prevented a com-
plete neurological examination. 
A complete blood count and biochemical 
analysis (total proteins and fractions, urea, creatinine, 
alanine aminotransferase, alkaline phosphatase, calci-
um) was perfomed and it was unremarkable. Abdomi-
nal ultrasound also did not revealed any abnormality. 
Nodular lesions of the neck and perianal regions were 
re-assessed through cytology, and an excisional biopsy 
was perfomed in a 2 cm nodule in the cervical region. 
Cytology revealed the presence of plasma cells 
with coarse chromatin, indistinct nuclei, considerable 
anisokaryosis and single nuclear pleomorphism, com-
patible with plasmacytoma. Histopathology showed 
predominance of oval-shaped plasma cell with eosino-
philic cytoplasm, round eccentric nucleus, moderate 
cellular pleomorphism, prominent anisocytosis and 
clumping chromatin. Giant cells were not observed but 
five mitotic figures were counted in 10 high power-
fields, characterizing an extramedullary plasmacytoma 
of the mature type [16]. A bone marrow sample was 
collected from the sternum and showed no increase of 
plasma cells (less than 3%) or cellular atypia. 
Due to the patient’s medical condition and 
suspicious of a myeloma-related disorder, the dog 
was hospitalized for pain control and replacement of 
dehydration deficit. Hydrocortisone1 (5 mg/kg) and 
methadone2 (0.3 mg/kg), were intravenously adminis-
tered, every 4 h. After 12 h the patient was still showing 
signs of pain and resistance to physical examination. A 
new analgesia protocol was performed, with continu-
ous infusion of morphine3 (0.2 mg/kg/h) and ketamine4 
10% (0.6 mg/kg/h). This protocol was effective in 
promoting patient’s comfort and pain relief, however, 
humanized euthanasia was elected, with the owner’s 
consent, due to the dog’s aggressive temper, associated 
with difficulty in administration of oral medication and 
poor clinical condition, and it was performed before 
radiographs, protein electrophoresis and Bence-Jones 
proteinuria could be investigated. 
At necropsy, a pale, friable and hemorrhagic 
mass was identified on the L3 lumbar vertebrae, associ-
ated with an osteolytic bone lesion and spinal cord com-
pression (Figure 2A). The histopathological slides were 
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Figure 1. Multiple skin nodules of plasma cell proliferation measuring one to two centimeters in a 11-year-old mixed breed dog with solitary osseous 
plasmacytoma.
stained with hematoxylin and eosin, which revealed 
proliferation of plasma cells, with pale perinuclear 
halo, moderate cellular pleomorphism, 10 binucleated 
cells and 10 mitotic figures per 10 high power fields. It 
was also seen myeloma-related lesions in the skin and 
subcutaneous (Figure 2B), prostate (Figure 2C), heart 
(Figure 2D), superficial mandibular and axillary lymph 
nodes. Based on the clinical and anatomopathological 
features, the diagnosis was defined as an extramedullary 
plasmacytoma of the mature type [16], with probably 
onset in lumbar vertebrae (SOP) and metastasis to the 
skin and subcutaneous, prostate, heart and superficial 
mandibular and axillary lymph nodes. 
DISCUSSION
SOP is a rare malignancy in humans and dogs 
that mainly affects bones of the axial skeleton such as 
mandible [1,15], vertebrae [14,22] and ribs [6], but it 
might as well occur in the femur [11] and tibia [10], 
in appendicular skeleton. Affected dogs are usually 
middle-aged to older, as described in this case. 
Dogs with vertebral SOP may present neurolo-
gical abnormalities related to spinal cord compression, 
which includes pain, paresis/paralysis, sensibility loss 
and Schiff-Sherrington syndrome [17], nevertheless 
although pain manifestation was evident in the reported 
case, semiological characterization was limited by the 
dog’s aggressive temper.  
According to the histophatological features, 
extramedullary plasmacytoma can be classified into 5 
diferent subtypes, presented in the Table 1: mature, cle-
aved, hyaline, asynchronous and polymorphous-blastic 
type. Although this classification has not shown rele-
vance in the prognosis [16], it was used in the present 
study, in order to contribute to the current knowledge 
of this uncommon disease.  In the present report, his-
topathological findings of the vertebral tumour were 
compatible with the extramedullary plasmacytoma of 
the mature type.
SOP’s biological behaviour remains poorly 
characterized. In humans 65-84% of the cases progress 
to multiple myeloma in 15 years resulting in poor 
prognosis [7,8]. A poor outcome for systemic involve-
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Figure 2. Anatomopathological features of a 11-year old mixed breed dog. A- L3 lumbar vertebrae: solitary osseous plasmacytoma associated with an 
osteolytic bone lesion and spinal cord compression. B- Skin: Plasma cell proliferation on skin nodules [H&E, 40x]. C- Prostate: Plasma cell infiltrative 
[H&E, 10x]. D- Heart: Plasma cell infiltrative within myocardial fibers [H&E, 40x].  
Table 1. Histopathological features for grading of the canine extramedullary plasmacytomas. 
Histopathologic type Nuclear morphology Number of giant cells Cytoplasm in the HE stain
Mature Oval-shaped Small number
Numerous cytoplasmic 
vacuoles or an eosinophilic 
fine-grained cytoplasm
Hyaline Sickle-shaped Small number Eosinophlic and centrally 
transparent
Cleaved Indented and cleaved Numerous Scarce cytoplasm
Asynchronous Blastic Numerous Eosinophilic and vacuolar 
cytoplasm
Polymorphous-blastic More or less blastic Numerous Generally has eosinophilic, 
vacuolar cytoplasm
ment was also demonstrated in dogs, in a retrospective 
study that included medical records of eight dogs 
with neurological abnormalities compatible to spinal 
cord compression, and histopathological diagnosis of 
SOP in the lumbar vertebrae [17]. In this study, six 
dogs presented other sites of plasma cell proliferation 
besides the vertebrae, including liver, spleen, kidney, 
mesenteric lymph nodes and oral mucosa. Neoplastic 
involvement of the bone marrow was detected in only 
two of these dogs and an overt bone marrow infiltration 
was also not detected in the reported case. Nevertheless 
multiple myeloma distribution in the bone marrow is 
often multifocal and plasma cell values below 10% do 
not exclude the possibility of such involvement [2]. 
In the present report, it was not possible to precise the 
time of disease development and onset of neurologi-
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cal signs, but the disease was present for at least one 
month, when skin nodules of plasma cell proliferation 
first appeared.  
In humans radiotherapy is the treatment of 
choice, however it is indicated in association to sur-
gery whenever spinal stabilization and/or spinal cord 
decompression are necessary [6,19]. A retrospective 
study showed a higher survival rate in patients with 
SOP in the axial skeleton, which received surgical 
treatment combined with radiotherapy (70.5%), if 
compared to those treated with surgery alone (46.4%) 
or radiotherapy alone (61.5%) [20].
Chemotherapy is the treatment of choice for 
multiple myeloma however its indication for SOP 
is conditioned to the evidence of systemic disease. 
Although it might delay its progression, early imple-
mentation of chemotherapy may favor the selection of 
resistant neoplastic clones, making it ineffective when 
progression to multiple myeloma occurs [4]. Melpha-
lan is the main drug used in management of multiple 
myeloma, and it can be orally administered to dogs in 
2 different schemes: a continuous low-dose regimen 
(0.1 mg/kg every 24 h for 10 days, followed by 0.05 
mg/ kg every 24 h continuously) or a pulse-dosing 
regimen (7 mg/m2 every 24 h for 5 consecutive days, 
every 3 weeks). Treatment efficacy may be increased 
when melphalan is combined to oral prednisolone 
at a dosage of 0.5 mg/kg daily, in the 10 first days, 
followed by the same dose, in alternated days for more 
60 days. Cyclophosphamide may be used in the first 
day of melphalan, at a dosage of 200 mg/m2, in order 
to achieve fast remission of clinical signs in patients 
with poor clinical condition, as well as a substitute to 
melphalan in the occurrence of thrombocytopenia after 
prolonged use. The median survival time is 540 days, 
and complete remission is seen in approximately 43% 
of cases, however 49% achieve partial remission [12]. 
In the reported case, the patient’s aggressive 
behaviour and medical condition limited diagnostic in-
vestigation and medical treatment, and euthanasia was 
carefully chosen along with the owner. However, until 
the decision could be made, analgesia was attempted 
and the analgesic protocol with continuous infusion of 
morphine and ketamine, showed a remarkable efficacy, 
differing from the protocol performed in a different 
study, in which tramadol (5 mg/kg) and dipyrone (25 
mg/kg) were administered every 8 h, along with ga-
bapentin (5 mg/kg) every 24 h [14]. 
CONCLUSION
This paper describes an unusual case of an extra-
-cutaneous extra-medullary plasmacytoma of the mature 
type, located in a lumbar vertebrae (SOP) of a dog with 
subsequent involvement of the skin and subcutaneous, 
prostate, heart, superficial mandibular and axillary lym-
ph nodes. Analgesic protocol with continuous infusion 
of morphine and ketamine was effective in this case. 
The prognosis for SOP with systemic involvement se-
ems poor, although it might be related to radiographical 
and histopathological features, presence of monoclonal 
hypergammaglobulinemia and Bence-Jones proteinuria, 
but this must be further investigated, alongside with 
surgical or medical treatment response. 
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